Sumitomo Teams With U.S. Fusion Startup On Cancer Treatments - Nikkei
April 8 (Reuters) - Nikkei:
SUMITOMO TEAMS WITH U.S. FUSION STARTUP ON CANCER TREATMENTS
SUMITOMO IS PARTNERING WITH U.S. NUCLEAR FUSION STARTUP SHINE TECHNOLOGIES TO ENTER THE ASIAN CANCER TREATMENT FIELD
PARTNERSHIP BETWEEN SUMITOMO AND SHINE WILL COVER A RANGE OF FIELDS INCLUDING RADIOACTIVE WASTE RECYCLING AND FUSION POWER GENERATION
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Nebius Stock: Can This AI Infrastructure Play Really Double in 2026?

Intel Better-Than-Expected Earnings Released, Stock Surges 20% After-Hours, AI Computing Power Enters CPU Moment?

Semiconductor Sector Continues to Rise, Should Retail Investors Buy Intel or AMD?
Google Bets $40B on Anthropic: Is Google Cloud the New Growth Engine as Meta Challenges Ad Dominance?

Intel Posts Best Day Since 1987 as Nvidia Market Cap Reclaims $5 Trillion: Is the AI Trade Overstretched?

Tradingkey







